John Sterling's profile photo

John Sterling

New York

Editor in Chief of Genetic Engineering & Biotechnology News (GEN) since 1985; BS degree in biology from CCNY and MA in journalism from Univ of Minnesota

Articles

  • 4 days ago | genengnews.com | John Sterling

    Home Topics Bioprocessing Genentech Plans to Invest More than $700 Million in New North Carolina... Female researcher looking through microscope in a laboratory. [Roche/Genentech] Female researcher looking through microscope in a laboratory. [Roche/Genentech] Genentech plans to invest more than $700 million in a new 700,000-ft2 drug manufacturing facility in Holly Springs, NC.

  • 1 week ago | genengnews.com | John Sterling

    Home News How Bacteria Synthesize an “Organic Dishwashing Liquid” to Degrade Oil Oil slick on sea surface. [Sergei Dubrovskii/Getty Images] Oil slick on sea surface. [Sergei Dubrovskii/Getty Images] The marine bacterium Alcanivorax borkumensis feeds on oil, multiplying rapidly in the wake of oil spills and thereby accelerating the elimination of the pollution, in many cases. It does this by producing an “organic dishwashing liquid,” which it uses to attach itself to oil droplets.

  • 1 week ago | genengnews.com | John Sterling

    Home Topics Bioprocessing First-time Production of an Artificial Human Platelet Lysate Credit: Manjurul/Getty Images Credit: Manjurul/Getty Images PL BioScience, a German life science company specializing in the production and development of human platelet lysate (HPL) for cell expansion, reported the first-time production of an artificial HPL cell culture solution.

  • 1 week ago | genengnews.com | John Sterling

    Home Topics Bioprocessing Astraveus Enters CAR-T Therapy Manufacturing Partnership with NecstGen Chimeric antigen receptor (CAR) T cell (blue) attacking non-Hodgkin's lymphoma cells (purple). Healthy red (discs) and white (translucent) blood cells are shown in the background, illustration. [Nemes Laszlo/Science Photo Library/Getty Images] Chimeric antigen receptor (CAR) T cell (blue) attacking non-Hodgkin's lymphoma cells (purple).

  • 1 week ago | genengnews.com | John Sterling

    Home Topics Bioprocessing BioChromatographix International Officially Launches in Singapore Credit: BioChromatographix Credit: BioChromatographix BioChromatographix International (BCI), which recently launched in Singapore, is focusing on downstream processing with a new class of Next-generation Monolithic Chromatography Media for gene therapy, cell therapy, and advanced biologics manufacturing.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
274
Tweets
31
DMs Open
No
John Sterling
John Sterling @JohnSterling4
13 Jan 22

Genetic Engineering & Biotechnology News (GEN) is looking for researchers and science students interested in exploring science writing as interns putting together short daily news stories. For details, contact John Sterling, Editor in Chief, at [email protected]

John Sterling
John Sterling @JohnSterling4
15 Mar 21

.@GENbio is looking for biotech, science, and pharma freelance writers in the US, Europe, Asia, and So America. Background in science essential and 1-2 years writing exp required. Email resume & writing samples to [email protected]

John Sterling
John Sterling @JohnSterling4
18 Aug 20

BIG #BlackInGenetics is an organization dedicated to amplifying the voices and work of Black-identifying geneticists across the U.S. and beyond. This is #Blackingeneticsweek.@GENbio